LifeStance Health Group Inc (NAS:LFST)
$ 9.65 +0.21 (+2.22%) Market Cap: 3.68 Bil Enterprise Value: 3.95 Bil PE Ratio: 160.83 PB Ratio: 2.53 GF Score: 57/100

Q4 2024 Lifestance Health Group Inc Earnings Call Transcript

Feb 27, 2025 / 01:30PM GMT
Release Date Price: $7.74 (+3.06%)

Key Points

Positve
  • LifeStance Health Group Inc (LFST) reported a 19% revenue growth to $1.25 billion for the full year 2024.
  • The company achieved an adjusted EBITDA of $120 million, representing a 103% increase and a 9.6% margin.
  • LifeStance Health Group Inc (LFST) delivered double-digit adjusted EBITDA margins for the first time as a public company.
  • The company generated significant positive free cash flow of $86 million for the year, exceeding expectations.
  • LifeStance Health Group Inc (LFST) successfully implemented a new operating model to streamline operations and improve performance.
Negative
  • The company faces downward pressure on total revenue per visit in early 2025 due to rate decreases from a single outlier payer.
  • LifeStance Health Group Inc (LFST) anticipates pressure on center margins due to clinician compensation increases.
  • The competitive environment for recruiting and retaining clinicians remains highly challenging.
  • The company expects lower free cash flow in 2025 due to changes in payroll cycles and higher capital expenditures.
  • LifeStance Health Group Inc (LFST) is cautious about the M&A environment, noting that valuations remain higher than desired.
Operator

Thank you for standing by. My name is Danielle, and I will be your conference operator today. At this time, I would like to welcome everyone to the Lifestance Health fourth quarter 2024 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. (Operator Instructions) Thank you.

I would now like to call over Monica Prokocki. Please go ahead.

Monica Prokocki
Lifestance Health Group Inc - Vice President - Finance and Investor Relations

Thank you, operator. Good morning, everyone, and welcome to Lifestance Health fourth quarter 2024 earnings conference call. I'm Monica Prokocki, Vice President of Finance and Investor Relations. Joining me today are Ken Burdick, Chief Executive Officer, and Dave Bourdon, Chief Financial Officer. We issued the earnings release and presentation before the market opened this morning. Both are available on the Investor Relations section of our website, investor.lifestance.com.

Before turning the call over to management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot